• 1
    Seely JM, Mayo JR, Miller RR, Muller NL. T1 lung cancer: prevalence of mediastinal nodal metastases and diagnostic accuracy of CT. Radiology. 1993; 186: 129132.
  • 2
    McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology. 1992; 182: 319323.
  • 3
    Libshitz HI, McKenna RJJr, Haynie TP, McMurtrey MJ, Mountain CT. Mediastinal evaluation in lung cancer. Radiology. 1984; 151: 295299.
  • 4
    Beyer T, Townsend DW, Blodgett TM. Dual-modality PET/CT tomography for clinical oncology. Q J Nucl Med. 2002; 46: 2434.
  • 5
    Scott WJ, Gobar LS, Terry JD, Dewan NA, Sunderland JJ. Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography. J Thorac Cardiovasc Surg. 1996; 111: 642648.
  • 6
    Shim SS, Lee KS, Chung MJ, Kim H, Kwon OJ, Kim S. Do hemodynamic studies of stage T1 lung cancer enable the prediction of hilar or mediastinal nodal metastasis? AJR Am J Roentgenol. 2006; 186: 981988.
  • 7
    Gdeedo A, Van Schil P, Corthouts B, Van Mieghem F, Van Meerbeeck J, Van Marck E. Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging. Eur Respir J. 1997; 10: 15471551.
  • 8
    Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s—meta-analytic comparison of PET and CT. Radiology. 1999; 213: 530536.
  • 9
    Yoon YC, Lee KS, Shim YM, Kim BT, Kim K, Kim TS. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection—prospective study. Radiology. 2003; 227: 764770.
  • 10
    Konishi J, Yamazaki K, Tsukamoto E, et al. Mediastinal lymph node staging in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Respiration. 2003; 70: 500506.
  • 11
    Shim SS, Lee KS, Kim B-T, et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology. 2005; 236: 10111019.
  • 12
    Kim B-T, Lee KS, Shim SS, et al. Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT—a prospective study. Radiology. 2006; 241: 501509.
  • 13
    Korean Center for Disease Control and Prevention. Annual report on the notified tuberculosis patients in Korea. Seoul, Republic of Korea: 2006 (in Korean).
  • 14
    GreeneFL, PageDL, FlemingID, et al., editors. AJCC Cancer Staging Manual, 6th ed. New York: Springer; 2002: 165177.
  • 15
    Hamblen SM, Lowe VJ. Clinical 18F-FDG oncology patient preparation techniques. J Nucl Med Technol. 2003; 31: 37.
  • 16
    Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest. 1997; 111: 17181723.
  • 17
    Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer. A review of the current evidence. Chest. 2003; 123: 137S146S.
  • 18
    Gonzalez-Stawinski GV, Lemaire A, Merchang F, et al. A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer. J Thoracic Cardiovasc Surg. 2003; 126: 19001905.
  • 19
    Reed CE, Harpole DH, Posther KE, et al. Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thoracic Cardiovasc Surg. 2003; 126: 19431951.
  • 20
    Grado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman JM, Coleman RE. Performance characteristics of a whole body PET scanner. J Nucl Med. 1994; 35: 13981406.